Paclitaxel and cisplatin with or without cetuximab in metastatic esophageal squamous cell carcinoma: a randomized, multicenter phase II trial

Lack of effective targeted therapy in metastatic esophageal squamous cell carcinoma (ESCC) underscores the urgent need for identifying new treatment approaches for this challenging disease. We sought to assess the addition of cetuximab to paclitaxel-cisplatin chemotherapy for first-line treatment in...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Zhihao Lu, Yanqiao Zhang, Qingxia Fan, Yueyin Pan, Da Jiang, Ping Lu, Jingdong Zhang, Xianglin Yuan, Jifeng Feng, Shujun Yang, Wenbin Yue, Lin Zhao, Yunhua Xu, Jinhua Luo, Lin Shen
Materialtyp: Artigo
Språk:Inglês
Publicerad: Elsevier 2022-05-01
Serie:The Innovation
Ämnen:
esophageal squamous cell carcinoma
cetuximab
EGFR
chemotherapy
Länkar:http://www.sciencedirect.com/science/article/pii/S2666675822000352
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk